Statistics
Publications
41
Citations
3.9K
H-Index
25
Active since
1996
Sridhar Chaganti is an author at University College London specializing in medicine, hematology, and oncology.
Publications per year
1996–2025
41
41
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Frederick L. Locke, David B. Miklos, Caron A. Jacobson et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text
Medicine, Hematology, Oncology +8
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
Jason R. Westin, Olalekan O. Oluwole, Marie José Kersten et al. · New England Journal of Medicine · 2023 · 410 citations · Full text
Medicine, Immunology, Oncology +17
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
Claire Roddie, Karamjeet Sandhu, Eleni Tholouli et al. · New England Journal of Medicine · 2024 · 196 citations · Full text
Medicine, Hematology, Oncology +15
Guidelines for the management of diffuse large B‐cell lymphoma
Sridhar Chaganti, Tim Illidge, Sally F. Barrington et al. · British Journal of Haematology · 2016 · 166 citations · Full text
Medicine, Hematology, Oncology +14
1–5 of 41